anurajms/meta_analysis huggingface dataset:
MESH terms:
Massage, reflexology and other manual methods for pain management in labour
1. Analgesics [therapeutic use]; 2. Cryotherapy [methods]; 3. Hyperthermia, Induced [methods]; 4. Labor Onset [physiology]; 5. Labor Pain [*therapy]; 6. Massage; 7. Music Therapy; 8. Pain Management [*methods]; 9. Randomized Controlled Trials as Topic;
MESH terms:
Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency
1. Administration, Oral; 2. Injections, Intramuscular; 3. Randomized Controlled Trials as Topic; 4. Vitamin B 12 [*administration & dosage]; 5. Vitamin B 12 Deficiency [*drug therapy]; 6. Vitamin B Complex [*administration & dosage];
MESH terms:
Aromatherapy for treatment of postoperative nausea and vomiting
1. 2-Propanol [*administration & dosage]; 2. Administration, Inhalation; 3. Antiemetics [*administration & dosage]; 4. Aromatherapy [*methods]; 5. Controlled Clinical Trials as Topic; 6. Plant Oils [*administration & dosage]; 7. Postoperative Nausea and Vomiting [*therapy]; 8. Randomized Controlled Trials as Topic; 9. Salvage Therapy [methods];
MESH terms:
Acupuncture for depression
1. Acupuncture Therapy [adverse effects, *methods]; 2. Antidepressive Agents [therapeutic use]; 3. Depression [drug therapy, *therapy]; 4. Psychotherapy; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; 7. Treatment Outcome;
MESH terms:
Prophylactic vitamin K for the prevention of vitamin K deficiency bleeding in preterm neonates
1. Biomarkers [metabolism]; 2. Infant Mortality; 3. Infant, Premature; 4. Injections, Intramuscular; 5. Injections, Intravenous; 6. Liver [metabolism]; 7. Protein Precursors [metabolism]; 8. Prothrombin [analysis, metabolism]; 9. Vitamin K [*administration & dosage, blood]; 10. Vitamin K 1 [analogs & derivatives, blood]; 11. Vitamin K Deficiency Bleeding [*prevention & control]; 12. Vitamins [*administration & dosage];
MESH terms:
Vitamin E for antipsychotic‐induced tardive dyskinesia
1. Antipsychotic Agents [*adverse effects]; 2. Disease Progression; 3. Dyskinesia, Drug‐Induced [*drug therapy, etiology]; 4. Patient Acceptance of Health Care [statistics & numerical data]; 5. Psychotic Disorders [drug therapy]; 6. Randomized Controlled Trials as Topic; 7. Schizophrenia [drug therapy]; 8. Vitamin E [adverse effects, *therapeutic use]; 9. Vitamins [adverse effects, *therapeutic use];
MESH terms:
Respiratory muscle training for multiple sclerosis
1. Breathing Exercises [*methods]; 2. Cough [physiopathology]; 3. Exhalation [physiology]; 4. Inhalation [physiology]; 5. Multiple Sclerosis [*complications]; 6. Randomized Controlled Trials as Topic; 7. Respiratory Muscles;
MESH terms:
Probiotics for the prevention of Clostridium difficile‐associated diarrhea in adults and children
1. *Clostridioides difficile; 2. Anti‐Bacterial Agents [*adverse effects]; 3. Diarrhea [microbiology, *prevention & control]; 4. Enterocolitis, Pseudomembranous [*complications, epidemiology]; 5. Incidence; 6. Probiotics [*therapeutic use]; 7. Randomized Controlled Trials as Topic;
MESH terms:
Antioxidants for preventing and reducing muscle soreness after exercise
1. *Dietary Supplements; 2. *Exercise; 3. *Food, Fortified; 4. Antioxidants [adverse effects, *therapeutic use]; 5. Myalgia [*drug therapy, etiology, *prevention & control]; 6. Randomized Controlled Trials as Topic; 7. Time Factors;
MESH terms:
Acupuncture for neuropathic pain in adults
1. *Acupuncture Therapy; 2. Analgesics [therapeutic use]; 3. Chronic Pain [*therapy]; 4. Drugs, Chinese Herbal [therapeutic use]; 5. Inositol [therapeutic use]; 6. Neuralgia [*therapy]; 7. Nimodipine [therapeutic use]; 8. Pain Measurement; 9. Quality of Life; 10. Randomized Controlled Trials as Topic; 11. Vitamin B 12 [analogs & derivatives, therapeutic use];
MESH terms:
Probiotics for vulvovaginal candidiasis in non‐pregnant women
1. Administration, Intravaginal; 2. Antifungal Agents [administration & dosage]; 3. Candidiasis, Vulvovaginal [prevention & control, *therapy]; 4. Clotrimazole [administration & dosage]; 5. Fluconazole [administration & dosage]; 6. Imidazoles [administration & dosage]; 7. Miconazole [administration & dosage]; 8. Probiotics [adverse effects, *therapeutic use]; 9. Randomized Controlled Trials as Topic; 10. Recurrence; 11. Secondary Prevention;
MESH terms:
Music therapy for depression
1. Anxiety [therapy]; 2. Combined Modality Therapy; 3. Depression [*therapy]; 4. Music Therapy [*methods]; 5. Patient Reported Outcome Measures; 6. Psychotherapy; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Treatment Outcome;
MESH terms:
Combined diet and exercise interventions for preventing gestational diabetes mellitus
1. *Diet; 2. *Exercise; 3. Cesarean Section [statistics & numerical data]; 4. Combined Modality Therapy [methods]; 5. Diabetes, Gestational [*prevention & control]; 6. Hypertension [epidemiology]; 7. Perinatal Mortality; 8. Perineum [injuries]; 9. Pregnancy Complications, Cardiovascular [epidemiology]; 10. Randomized Controlled Trials as Topic;
MESH terms:
Acupuncture or acupressure for induction of labour
1. *Acupressure; 2. *Acupuncture Therapy; 3. Cervical Ripening; 4. Cesarean Section [statistics & numerical data]; 5. Labor, Induced [*methods]; 6. Oxytocics; 7. Oxytocin; 8. Randomized Controlled Trials as Topic;
MESH terms:
Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults
1. Electroacupuncture; 2. Exercise; 3. Fibromyalgia [*therapy]; 4. Hydrotherapy; 5. Placebos [therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Transcutaneous Electric Nerve Stimulation [*methods];
MESH terms:
Yoga for epilepsy
1. *Yoga; 2. Acceptance and Commitment Therapy; 3. Drug Resistant Epilepsy [etiology, *therapy]; 4. Quality of Life; 5. Randomized Controlled Trials as Topic; 6. Seizures [therapy]; 7. Stress, Psychological [complications, therapy];
MESH terms:
Yoga as part of a package of care versus standard care for schizophrenia
1. *Yoga; 2. Combined Modality Therapy; 3. Patient Dropouts [statistics & numerical data]; 4. Quality of Life; 5. Randomized Controlled Trials as Topic; 6. Schizophrenia [*therapy]; 7. Standard of Care;
MESH terms:
Yoga versus non‐standard care for schizophrenia
1. *Exercise Therapy; 2. *Yoga; 3. Patient Dropouts [statistics & numerical data]; 4. Psychotherapy; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; 7. Schizophrenia [*therapy]; 8. Schizophrenic Psychology;
MESH terms:
Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults
1. Neuralgia [etiology, *therapy]; 2. Pain Measurement; 3. Quality of Life; 4. Transcutaneous Electric Nerve Stimulation [*methods];
MESH terms:
Pharmacological and mechanical interventions for labour induction in outpatient settings
1. *Ambulatory Care; 2. Acupuncture Therapy [methods]; 3. Cesarean Section [statistics & numerical data]; 4. Dinoprostone [administration & dosage]; 5. Feasibility Studies; 6. Intensive Care, Neonatal [statistics & numerical data]; 7. Labor, Induced [*methods]; 8. Misoprostol [administration & dosage]; 9. Oxytocics; 10. Randomized Controlled Trials as Topic;
MESH terms:
Vitamin A supplements for reducing mother‐to‐child HIV transmission
1. *Pregnancy Complications, Infectious; 2. HIV Infections [mortality, prevention & control, *transmission]; 3. Infectious Disease Transmission, Vertical [*prevention & control]; 4. Randomized Controlled Trials as Topic; 5. Treatment Outcome; 6. Vitamin A [*administration & dosage]; 7. Vitamin A Deficiency [*complications, drug therapy]; 8. Vitamins [*administration & dosage];
MESH terms:
Whole grain cereals for the primary or secondary prevention of cardiovascular disease
1. Cardiovascular Diseases [blood, *prevention & control]; 2. Cholesterol [blood]; 3. Cholesterol, HDL [blood]; 4. Cholesterol, LDL [blood]; 5. Coronary Disease [blood, diet therapy]; 6. *Edible Grain; 7. Randomized Controlled Trials as Topic; 8. Risk Factors; 9. Triglycerides [blood];
MESH terms:
Homocysteine‐lowering interventions for preventing cardiovascular events
1. Angina Pectoris [prevention & control]; 2. Cardiovascular Diseases [etiology, *prevention & control]; 3. Cause of Death; 4. Folic Acid [therapeutic use]; 5. Hyperhomocysteinemia [complications, *therapy]; 6. Myocardial Infarction [epidemiology, prevention & control]; 7. Randomized Controlled Trials as Topic; 8. Risk Factors; 9. Stroke [epidemiology, prevention & control]; 10. Vitamin B 12 [therapeutic use]; 11. Vitamin B 6 [therapeutic use]; 12. Vitamin B Complex [*therapeutic use];
MESH terms:
Low glycaemic index diets for the prevention of cardiovascular disease
1. Blood Glucose [metabolism]; 2. Blood Pressure; 3. Cardiovascular Diseases [metabolism, *prevention & control]; 4. Dietary Carbohydrates [administration & dosage, *metabolism]; 5. Fasting [metabolism]; 6. *Glycemic Index; 7. Lipids [blood]; 8. Primary Prevention; 9. Secondary Prevention; 10. Weight Loss;
MESH terms:
Antioxidant vitamin and mineral supplements for preventing age‐related macular degeneration
1. *Dietary Supplements; 2. Antioxidants [*administration & dosage, adverse effects]; 3. Ascorbic Acid [administration & dosage, adverse effects]; 4. Drug Combinations; 5. Macular Degeneration [*prevention & control]; 6. Minerals [administration & dosage]; 7. Randomized Controlled Trials as Topic; 8. Vitamin E [administration & dosage, adverse effects]; 9. Vitamins [*administration & dosage, adverse effects]; 10. alpha‐Tocopherol [administration & dosage]; 11. beta Carotene [administration & dosage];
MESH terms:
Deep brain and cortical stimulation for epilepsy
1. Anterior Thalamic Nuclei; 2. Cerebral Cortex; 3. Deep Brain Stimulation [instrumentation, *methods]; 4. Electrodes, Implanted [adverse effects]; 5. Epilepsy [*therapy]; 6. Hippocampus; 7. Mediodorsal Thalamic Nucleus; 8. Nucleus Accumbens; 9. Outcome Assessment, Health Care; 10. Randomized Controlled Trials as Topic;
MESH terms:
Continuous support for women during childbirth
1. *Delivery, Obstetric; 2. *Labor, Obstetric; 3. *Personal Autonomy; 4. Cesarean Section; 5. Doulas; 6. Pregnancy Outcome; 7. Professional‐Patient Relations;
MESH terms:
Wendan decoction (Traditional Chinese medicine) for schizophrenia
1. Antipsychotic Agents [therapeutic use]; 2. Chlorpromazine [therapeutic use]; 3. Drug Therapy, Combination; 4. Drugs, Chinese Herbal [adverse effects, *therapeutic use]; 5. Dyskinesia, Drug‐Induced [etiology]; 6. Patient Satisfaction; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Risperidone [therapeutic use]; 10. Schizophrenia [*drug therapy];
MESH terms:
Music therapy for people with schizophrenia and schizophrenia‐like disorders
1. Interpersonal Relations; 2. Music Therapy [*methods]; 3. Quality of Life; 4. Randomized Controlled Trials as Topic; 5. Schizophrenia [*therapy]; 6. Schizophrenic Psychology;
MESH terms:
Branched‐chain amino acids for people with hepatic encephalopathy
1. Administration, Oral; 2. Amino Acids, Branched‐Chain [adverse effects, *therapeutic use]; 3. Bias; 4. Diarrhea [etiology]; 5. Hepatic Encephalopathy [*drug therapy, mortality]; 6. Injections, Intravenous; 7. Nausea [etiology]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic;
MESH terms:
Therapeutic ultrasound for venous leg ulcers
1. *Ultrasonic Therapy [adverse effects, economics, methods]; 2. *Wound Healing; 3. Quality of Life; 4. Randomized Controlled Trials as Topic; 5. Time Factors; 6. Treatment Outcome; 7. Varicose Ulcer [*therapy];
MESH terms:
Effect of cocoa on blood pressure
1. Blood Pressure [drug effects]; 2. Cacao [*chemistry]; 3. Flavonols [adverse effects, *therapeutic use]; 4. Hypertension [*drug therapy]; 5. Randomized Controlled Trials as Topic;
MESH terms:
Vitamin E for Alzheimer's dementia and mild cognitive impairment
1. Activities of Daily Living; 2. Alzheimer Disease [*drug therapy, mortality]; 3. Antioxidants [adverse effects, *therapeutic use]; 4. Cognition [drug effects]; 5. Cognitive Dysfunction [*drug therapy, mortality]; 6. Disease Progression; 7. Outcome Assessment, Health Care; 8. Randomized Controlled Trials as Topic; 9. Vitamin E [adverse effects, *therapeutic use]; 10. alpha‐Tocopherol [adverse effects, *therapeutic use];
MESH terms:
Arginine supplementation for prevention of necrotising enterocolitis in preterm infants
1. Arginine [adverse effects, *therapeutic use]; 2. Cause of Death; 3. Enterocolitis, Necrotizing [epidemiology, *prevention & control]; 4. Glutamine [therapeutic use]; 5. Hypotension [chemically induced]; 6. Infant, Premature; 7. Infant, Premature, Diseases [epidemiology, *prevention & control]; 8. Numbers Needed To Treat; 9. Randomized Controlled Trials as Topic;
MESH terms:
L‐carnitine for cognitive enhancement in people without cognitive impairment
1. Attention [drug effects]; 2. Carnitine [*therapeutic use]; 3. Cognition [*drug effects]; 4. Memory [drug effects]; 5. Memory, Short‐Term [drug effects]; 6. Nootropic Agents [*therapeutic use]; 7. Publication Bias; 8. Randomized Controlled Trials as Topic; 9. Reaction Time [drug effects];
MESH terms:
Calcium and phosphorus supplementation of human milk for preterm infants
1. *Dietary Supplements; 2. *Milk, Human; 3. Alkaline Phosphatase [blood]; 4. Calcium [*administration & dosage]; 5. Infant, Premature; 6. Phosphorus [*administration & dosage]; 7. Randomized Controlled Trials as Topic;
MESH terms:
Different types of dietary advice for women with gestational diabetes mellitus
1. Caloric Restriction; 2. Cesarean Section [statistics & numerical data]; 3. Diabetes, Gestational [*diet therapy]; 4. Diet, Carbohydrate-Restricted; 5. Diet, Diabetic; 6. Dietary Carbohydrates [administration & dosage]; 7. Dietary Fiber [administration & dosage]; 8. Glycemic Index; 9. Hypertension [epidemiology]; 10. Pregnancy Complications, Cardiovascular [epidemiology]; 11. Randomized Controlled Trials as Topic;
MESH terms:
Probiotics for people with hepatic encephalopathy
1. Cause of Death; 2. Gastrointestinal Agents [*therapeutic use]; 3. Hepatic Encephalopathy [mortality, *therapy]; 4. Lactulose [*therapeutic use]; 5. Probiotics [*therapeutic use]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic;
MESH terms:
Acupuncture for acute hordeolum
1. *Acupuncture Therapy [adverse effects]; 2. Acute Disease; 3. Anti-Bacterial Agents [therapeutic use]; 4. Hordeolum [*therapy]; 5. Hyperthermia, Induced [methods]; 6. Randomized Controlled Trials as Topic; 7. Recurrence;
MESH terms:
Music interventions for acquired brain injury
1. Acoustic Stimulation [methods]; 2. Aphasia [rehabilitation]; 3. Brain Damage, Chronic [*rehabilitation]; 4. Brain Injuries [complications, *rehabilitation]; 5. Gait Disorders, Neurologic [etiology, *rehabilitation]; 6. Music Therapy [*methods]; 7. Randomized Controlled Trials as Topic; 8. Stroke [complications]; 9. Walk Test;
MESH terms:
Topical capsaicin (high concentration) for chronic neuropathic pain in adults
1. Administration, Topical; 2. Analgesics [*administration & dosage, adverse effects]; 3. Capsaicin [*administration & dosage, adverse effects]; 4. Chronic Pain [*drug therapy]; 5. Diabetic Neuropathies [drug therapy]; 6. HIV Infections [complications]; 7. Neuralgia [*drug therapy]; 8. Neuralgia, Postherpetic [drug therapy]; 9. Numbers Needed To Treat; 10. Ointments; 11. Pain, Postoperative [drug therapy]; 12. Randomized Controlled Trials as Topic;
MESH terms:
Dietary advice interventions in pregnancy for preventing gestational diabetes mellitus
1. *Diet; 2. *Glycemic Index; 3. Adiposity; 4. Birth Weight; 5. Cesarean Section [statistics & numerical data]; 6. Diabetes, Gestational [*prevention & control]; 7. Dietary Fiber [*administration & dosage]; 8. Randomized Controlled Trials as Topic;
MESH terms:
Longchain polyunsaturated fatty acid supplementation in preterm infants
1. *Dietary Supplements; 2. Arachidonic Acid [administration & dosage]; 3. Docosahexaenoic Acids [administration & dosage]; 4. Fatty Acids, Unsaturated [*administration & dosage]; 5. Infant Formula [*chemistry]; 6. Infant Nutritional Physiological Phenomena; 7. Infant, Premature [*growth & development]; 8. Intelligence [physiology]; 9. Randomized Controlled Trials as Topic; 10. Vision, Ocular [physiology]; 11. Visual Acuity [*physiology];
MESH terms:
Nutrient‐enriched formula versus standard formula for preterm infants following hospital discharge
1. *Infant Formula [standards]; 2. Child Development [*physiology]; 3. Dietary Proteins [administration & dosage]; 4. Energy Intake [*physiology]; 5. Infant Nutritional Physiological Phenomena; 6. Infant, Low Birth Weight [growth & development]; 7. Infant, Premature [*growth & development]; 8. Patient Discharge; 9. Randomized Controlled Trials as Topic;
MESH terms:
Electrical stimulation with non‐implanted electrodes for overactive bladder in adults
1. Electric Stimulation Therapy [instrumentation, *methods]; 2. Electrodes; 3. Pelvic Floor; 4. Randomized Controlled Trials as Topic; 5. Urinary Bladder, Overactive [*therapy]; 6. Urinary Incontinence, Urge [*therapy];
MESH terms:
Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months
1. Gluconates [administration & dosage]; 2. Pneumonia [epidemiology, *prevention & control]; 3. Randomized Controlled Trials as Topic; 4. Zinc Acetate [administration & dosage]; 5. Zinc Compounds [*administration & dosage]; 6. Zinc Sulfate [administration & dosage];
MESH terms:
Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children
1. Acute Disease; 2. Administration, Oral; 3. Astragalus propinquus; 4. Drugs, Chinese Herbal [*therapeutic use]; 5. Respiratory Tract Infections [*prevention & control];
MESH terms:
Nutritional supplementation for hip fracture aftercare in older people
1. *Aftercare; 2. *Dietary Supplements [adverse effects]; 3. Cause of Death; 4. Hip Fractures [*complications, mortality]; 5. Malnutrition [*diet therapy, mortality]; 6. Nutritional Support [adverse effects, *methods]; 7. Randomized Controlled Trials as Topic;
MESH terms:
Zinc supplementation for tinnitus
1. Administration, Oral; 2. Randomized Controlled Trials as Topic; 3. Surveys and Questionnaires; 4. Tinnitus [*therapy]; 5. Treatment Outcome; 6. Zinc [administration & dosage, *therapeutic use];
MESH terms:
Transcutaneous electrical stimulation (TES) for treatment of constipation in children
1. *Transcutaneous Electric Nerve Stimulation; 2. Chronic Disease; 3. Constipation [*therapy]; 4. Randomized Controlled Trials as Topic;
MESH terms:
Vitamin D supplementation for preventing infections in children under five years of age
1. Diarrhea [epidemiology, *prevention & control]; 2. Incidence; 3. Malaria [prevention & control]; 4. Pneumonia [epidemiology, *prevention & control]; 5. Randomized Controlled Trials as Topic; 6. Tuberculosis, Pulmonary [prevention & control]; 7. Vitamin D [*administration & dosage, blood]; 8. Vitamin D Deficiency [epidemiology]; 9. Vitamins [*administration & dosage];
MESH terms:
Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD)
1. *Hyperbaric Oxygenation [adverse effects]; 2. Autism Spectrum Disorder [*therapy]; 3. Cognition; 4. Communication; 5. Interpersonal Relations; 6. Randomized Controlled Trials as Topic;
MESH terms:
Methods of milk expression for lactating women
1. *Lactation; 2. *Randomized Controlled Trials as Topic; 3. Breast Milk Expression [instrumentation, *methods, statistics & numerical data]; 4. Personal Satisfaction; 5. Specimen Handling [instrumentation, *methods];
MESH terms:
Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
1. *Developing Countries; 2. *Dietary Supplements [adverse effects]; 3. *Infant Mortality; 4. Breast Feeding; 5. Cause of Death; 6. Diarrhea [epidemiology]; 7. Lactation; 8. Milk, Human [chemistry]; 9. Postpartum Period; 10. Randomized Controlled Trials as Topic; 11. Respiratory Tract Infections [epidemiology]; 12. Vitamin A [*administration & dosage, adverse effects, physiology]; 13. Vitamin A Deficiency [mortality, *therapy]; 14. Vitamins [*administration & dosage, adverse effects];
MESH terms:
Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders
1. Fatty Acids, Omega-3 [therapeutic use]; 2. Fatty Acids, Omega-6 [therapeutic use]; 3. Fatty Acids, Unsaturated [*therapeutic use]; 4. Learning Disabilities [*drug therapy];
MESH terms:
Routine vitamin A supplementation for the prevention of blindness due to measles infection in children
1. Blindness [etiology, *prevention & control]; 2. Measles [*complications]; 3. Randomized Controlled Trials as Topic; 4. Vitamin A [*administration & dosage, blood]; 5. Vitamins [*administration & dosage, blood];
MESH terms:
Acupuncture for stroke rehabilitation
1. *Acupuncture Therapy; 2. *Stroke Rehabilitation; 3. Activities of Daily Living; 4. Convalescence; 5. Randomized Controlled Trials as Topic;
MESH terms:
Kangaroo mother care to reduce morbidity and mortality in low birthweight infants
1. *Infant Mortality; 2. *Kangaroo‐Mother Care Method; 3. Bacterial Infections [prevention & control]; 4. Breast Feeding [statistics & numerical data]; 5. Infant Care [methods]; 6. Infant, Low Birth Weight [*growth & development]; 7. Infant, Premature, Diseases [mortality, prevention & control]; 8. Length of Stay; 9. Object Attachment; 10. Physical Stimulation [*methods]; 11. Randomized Controlled Trials as Topic; 12. Weight Gain;
MESH terms:
Vitamin A supplementation to prevent mortality and short‐ and long‐term morbidity in very low birth weight infants
1. *Infant, Very Low Birth Weight; 2. Infant, Premature; 3. Infant, Premature, Diseases [mortality, *prevention & control]; 4. Lung Diseases [mortality, *prevention & control]; 5. Randomized Controlled Trials as Topic; 6. Vitamin A [*therapeutic use]; 7. Vitamins [*therapeutic use];
MESH terms:
Fish oil for kidney transplant recipients
1. *Calcineurin Inhibitors; 2. Blood Pressure [drug effects, physiology]; 3. Fish Oils [adverse effects, *therapeutic use]; 4. Graft Rejection [*prevention & control]; 5. Graft Survival [*drug effects]; 6. Kidney [drug effects, physiology]; 7. Kidney Transplantation [*mortality]; 8. Lipids [blood]; 9. Randomized Controlled Trials as Topic;
MESH terms:
Polyunsaturated fatty acid supplementation for drug‐resistant epilepsy
1. Docosahexaenoic Acids [therapeutic use]; 2. Drug Resistant Epilepsy [*therapy]; 3. Eicosapentaenoic Acid [therapeutic use]; 4. Fatty Acids, Omega‐3 [*therapeutic use]; 5. Fatty Acids, Unsaturated [*therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Treatment Outcome;
MESH terms:
Cycled light in the intensive care unit for preterm and low birth weight infants
1. *Photoperiod; 2. Age Factors; 3. Body Weight; 4. Infant, Low Birth Weight [*growth & development]; 5. Infant, Premature [*growth & development]; 6. Intensive Care Units, Neonatal; 7. Lighting [adverse effects, *methods]; 8. Retinopathy of Prematurity [epidemiology]; 9. Weight Gain;
MESH terms:
Xylitol for preventing acute otitis media in children up to 12 years of age
1. Acute Disease; 2. Chewing Gum; 3. Gels [therapeutic use]; 4. Otitis Media [*prevention & control]; 5. Randomized Controlled Trials as Topic; 6. Sweetening Agents [adverse effects, *therapeutic use]; 7. Xylitol [adverse effects, *therapeutic use];
MESH terms:
Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease
1. *Transcranial Direct Current Stimulation; 2. Dyskinesias [physiopathology, therapy]; 3. Parkinson Disease [physiopathology, *therapy]; 4. Quality of Life; 5. Randomized Controlled Trials as Topic;
MESH terms:
Nutritional supplements for people being treated for active tuberculosis
1. *Dietary Supplements; 2. Antitubercular Agents [therapeutic use]; 3. Energy Intake; 4. HIV Infections [complications, mortality]; 5. Malnutrition [complications, *diet therapy]; 6. Micronutrients [administration & dosage]; 7. Randomized Controlled Trials as Topic; 8. Tuberculosis [complications, *diet therapy, drug therapy, mortality];
MESH terms:
Acupuncture and related interventions for symptoms of chronic kidney disease
1. Acupressure; 2. Acupuncture Points; 3. Acupuncture Therapy [adverse effects, *methods]; 4. Depression [therapy]; 5. Electroacupuncture; 6. Fatigue [therapy]; 7. Moxibustion; 8. Nutritional Status; 9. Pruritus [etiology, therapy]; 10. Quality of Life; 11. Randomized Controlled Trials as Topic; 12. Renal Insufficiency, Chronic [complications, psychology, *therapy]; 13. Symptom Assessment;
MESH terms:
Acupuncture for the prevention of episodic migraine
1. *Acupuncture Therapy [adverse effects]; 2. Migraine Disorders [drug therapy, *prevention & control]; 3. Migraine with Aura [prevention & control]; 4. Migraine without Aura [prevention & control]; 5. Randomized Controlled Trials as Topic;
MESH terms:
Tai Chi for chronic obstructive pulmonary disease (COPD)
1. *Tai Ji; 2. Breathing Exercises [*methods]; 3. Pulmonary Disease, Chronic Obstructive [physiopathology, psychology, *therapy]; 4. Quality of Life; 5. Randomized Controlled Trials as Topic; 6. Walking;
MESH terms:
Hypnosis for pain management during labour and childbirth
1. Analgesia, Obstetrical [*methods]; 2. Hypnosis [*methods]; 3. Labor Pain [psychology, *therapy]; 4. Labor, Obstetric [psychology]; 5. Length of Stay; 6. Patient Satisfaction; 7. Randomized Controlled Trials as Topic; 8. Time Factors;
MESH terms:
Vitamin supplementation for preventing miscarriage
1. Abortion, Habitual [prevention & control]; 2. Abortion, Spontaneous [*prevention & control]; 3. Antioxidants [administration & dosage]; 4. Ascorbic Acid [administration & dosage]; 5. Dietary Supplements [*adverse effects]; 6. Folic Acid [administration & dosage]; 7. Iron [administration & dosage]; 8. Pre‐Eclampsia [prevention & control]; 9. Pregnancy Outcome; 10. Pregnancy, Multiple; 11. Prenatal Care; 12. Randomized Controlled Trials as Topic; 13. Stillbirth; 14. Vitamin A [administration & dosage]; 15. Vitamins [*administration & dosage, adverse effects];
MESH terms:
Yoga for asthma
1. *Yoga; 2. Asthma [*therapy]; 3. Randomized Controlled Trials as Topic;
MESH terms:
Acupuncture for the prevention of tension‐type headache
1. Acupuncture Therapy [*methods]; 2. Exercise; 3. Massage; 4. Physical Therapy Modalities; 5. Randomized Controlled Trials as Topic; 6. Tension‐Type Headache [*prevention & control];
MESH terms:
Glutamine supplementation to prevent morbidity and mortality in preterm infants
1. *Dietary Supplements; 2. *Infant Mortality; 3. *Infant Nutritional Physiological Phenomena; 4. *Infant, Premature; 5. Glutamine [*administration & dosage]; 6. Infant, Very Low Birth Weight; 7. Randomized Controlled Trials as Topic;
MESH terms:
Omega‐3 fatty acids for the treatment of dementia
1. Alzheimer Disease [*drug therapy]; 2. Cognition [drug effects]; 3. Fatty Acids, Omega‐3 [*therapeutic use]; 4. Randomized Controlled Trials as Topic;
MESH terms:
Padma 28 for intermittent claudication
1. *Walking; 2. Intermittent Claudication [*drug therapy]; 3. Placebo Effect; 4. Plant Extracts [adverse effects, *therapeutic use]; 5. Randomized Controlled Trials as Topic; 6. Time Factors;
MESH terms:
Melatonin for women in pregnancy for neuroprotection of the fetus
1. *Neuroprotection; 2. Fetus [*drug effects]; 3. Melatonin [*administration & dosage]; 4. Neuroprotective Agents [*administration & dosage];
MESH terms:
Vitamin A supplementation for postpartum women
1. *Postpartum Period; 2. Infant Mortality; 3. Maternal Mortality; 4. Milk, Human [chemistry]; 5. Randomized Controlled Trials as Topic; 6. Vitamin A [*administration & dosage, analysis]; 7. Vitamin A Deficiency [drug therapy]; 8. Vitamins [*administration & dosage];
MESH terms:
Dietary advice for people with schizophrenia
1. *Counseling; 2. *Diet; 3. *Life Style; 4. *Schizophrenia;
MESH terms:
Dietary supplements for dysmenorrhoea
1. *Dietary Supplements; 2. Anti‐Inflammatory Agents, Non‐Steroidal [therapeutic use]; 3. Dysmenorrhea [diet therapy, *therapy]; 4. Magnesium [therapeutic use]; 5. Phytotherapy [*methods]; 6. Randomized Controlled Trials as Topic; 7. Thiamine [therapeutic use]; 8. Vitamin B 6 [therapeutic use]; 9. Vitamin E [therapeutic use];
MESH terms:
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
1. Antihypertensive Agents [*therapeutic use]; 2. Bias; 3. Blood Pressure [drug effects]; 4. Diastole [drug effects]; 5. Hypertension [*drug therapy]; 6. Randomized Controlled Trials as Topic; 7. Systole [drug effects]; 8. Ubiquinone [*analogs & derivatives, deficiency, therapeutic use];
MESH terms:
Puerarin for ischaemic stroke
1. Acute Disease; 2. Brain Ischemia [drug therapy, mortality]; 3. Isoflavones [*therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. Stroke [*drug therapy, mortality]; 6. Vasodilator Agents [*therapeutic use];
MESH terms:
Antioxidant treatments for schizophrenia
1. Acetylcysteine [therapeutic use]; 2. Allopurinol [therapeutic use]; 3. Antioxidants [*therapeutic use]; 4. Antipsychotic Agents [*therapeutic use]; 5. Ascorbic Acid [therapeutic use]; 6. Dehydroepiandrosterone [therapeutic use]; 7. Drug Therapy, Combination [methods]; 8. Free Radical Scavengers [*therapeutic use]; 9. Ginkgo biloba; 10. Oxidative Stress [*drug effects]; 11. Randomized Controlled Trials as Topic; 12. Schizophrenia [*drug therapy, metabolism]; 13. Selegiline [therapeutic use]; 14. Vitamin E [therapeutic use]; 15. Vitamins [therapeutic use];
MESH terms:
Chinese herbal medicines for unexplained recurrent miscarriage
1. Abortion, Habitual [*prevention & control]; 2. Birth Rate; 3. Drugs, Chinese Herbal [*therapeutic use]; 4. Hormones [therapeutic use]; 5. Live Birth; 6. Pregnancy Rate; 7. Psychotherapy; 8. Randomized Controlled Trials as Topic; 9. Tocolytic Agents [therapeutic use];
MESH terms:
Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache
1. *Hyperbaric Oxygenation; 2. *Oxygen Inhalation Therapy; 3. Cluster Headache [*therapy]; 4. Migraine Disorders [*therapy]; 5. Randomized Controlled Trials as Topic;
MESH terms:
Interventions for central serous chorioretinopathy: a network meta‐analysis
1. Carbonic Anhydrase Inhibitors [therapeutic use]; 2. Central Serous Chorioretinopathy [*therapy]; 3. Helicobacter Infections [drug therapy]; 4. Helicobacter pylori; 5. Laser Therapy [methods]; 6. Photochemotherapy [methods]; 7. Propranolol [therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Remission, Spontaneous; 10. Treatment Outcome; 11. Vascular Endothelial Growth Factor A [antagonists & inhibitors]; 12. Visual Acuity; 13. Watchful Waiting;
MESH terms:
Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting
1. *Acupuncture Points; 2. *Wrist; 3. Antiemetics [therapeutic use]; 4. Postoperative Nausea and Vomiting [*prevention & control]; 5. Randomized Controlled Trials as Topic;
MESH terms:
Ozone therapy for treating foot ulcers in people with diabetes
1. Anti‐Bacterial Agents [therapeutic use]; 2. Diabetes Mellitus, Type 1 [*complications]; 3. Diabetes Mellitus, Type 2 [*complications]; 4. Diabetic Foot [*therapy]; 5. Ozone [*therapeutic use]; 6. Randomized Controlled Trials as Topic;
MESH terms:
Vitamin A supplementation during pregnancy for maternal and newborn outcomes
1. Anemia [prevention & control]; 2. Infant Mortality; 3. Maternal Mortality; 4. Night Blindness [drug therapy]; 5. Pregnancy Complications [*drug therapy]; 6. Pregnancy Complications, Infectious [drug therapy]; 7. Vitamin A [*administration & dosage]; 8. Vitamin A Deficiency [*drug therapy]; 9. Vitamins [*administration & dosage];
MESH terms:
Yoga versus standard care for schizophrenia
1. *Schizophrenic Psychology; 2. *Yoga; 3. Activities of Daily Living; 4. Exercise; 5. Health Status; 6. Interpersonal Relations; 7. Negativism; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; 10. Schizophrenia [*therapy];
MESH terms:
Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients
1. *Cordyceps; 2. *Kidney Transplantation [mortality]; 3. Adjuvants, Immunologic [*therapeutic use]; 4. Azathioprine [therapeutic use]; 5. Cyclosporine [therapeutic use]; 6. Drugs, Chinese Herbal [*therapeutic use]; 7. Graft Rejection [*prevention & control]; 8. Graft Survival [*drug effects]; 9. Immunosuppressive Agents [*therapeutic use]; 10. Medicine, Chinese Traditional; 11. Randomized Controlled Trials as Topic;
MESH terms:
Interventions for preventing and treating low‐back and pelvic pain during pregnancy
1. *Exercise Therapy; 2. Acupuncture Therapy; 3. Back Pain [prevention & control, *therapy]; 4. Braces; 5. Low Back Pain [prevention & control, therapy]; 6. Manipulation, Osteopathic; 7. Pelvic Pain [prevention & control, *therapy]; 8. Pregnancy Complications [prevention & control, *therapy]; 9. Randomized Controlled Trials as Topic; 10. Sick Leave [statistics & numerical data];
MESH terms:
Vitamin C supplementation in pregnancy
1. Anemia [prevention & control]; 2. Ascorbic Acid [*administration & dosage]; 3. *Dietary Supplements; 4. Fetal Growth Retardation [prevention & control]; 5. Pre-Eclampsia [prevention & control]; 6. Pregnancy Complications [*prevention & control]; 7. Pregnancy Complications, Hematologic [prevention & control]; 8. Randomized Controlled Trials as Topic; 9. Vitamins [*administration & dosage];
MESH terms:
Nut consumption for the primary prevention of cardiovascular disease
1. *Nuts; 2. Blood Pressure; 3. Cardiovascular Diseases [*prevention & control]; 4. Lipids [blood]; 5. Primary Prevention [*methods]; 6. Randomized Controlled Trials as Topic;
MESH terms:
Vitamin K for the primary prevention of cardiovascular disease
1. Antifibrinolytic Agents [*administration & dosage]; 2. Cardiovascular Diseases [*prevention & control]; 3. Primary Prevention [methods]; 4. Vitamin K 2 [*administration & dosage];
MESH terms:
Interventions for nausea and vomiting in early pregnancy
1. Acupuncture Therapy [methods]; 2. Antiemetics [therapeutic use]; 3. Morning Sickness [etiology, therapy]; 4. Nausea [etiology, *therapy]; 5. Phytotherapy [methods]; 6. Pregnancy Complications [*therapy]; 7. Randomized Controlled Trials as Topic; 8. Treatment Outcome; 9. Vitamin B 6 [therapeutic use]; 10. Vitamin B Complex [therapeutic use]; 11. Vomiting [etiology, *therapy]; 12. Zingiber officinale [chemistry];
MESH terms:
Vitamin E supplementation in pregnancy
1. *Dietary Supplements [adverse effects]; 2. Antioxidants [*administration & dosage, adverse effects]; 3. Infant, Small for Gestational Age; 4. Pre‐Eclampsia [*prevention & control]; 5. Pregnancy Complications [prevention & control]; 6. Pregnancy Outcome; 7. Randomized Controlled Trials as Topic; 8. Vitamin E [*administration & dosage, adverse effects];
MESH terms:
Electromagnetic therapy for treating pressure ulcers
1. Magnetic Field Therapy [*methods]; 2. Pressure Ulcer [*therapy]; 3. Randomized Controlled Trials as Topic; 4. Wound Healing;
MESH terms:
Massage for low‐back pain
1. Acute Pain [therapy]; 2. Bias; 3. Chronic Pain [therapy]; 4. Low Back Pain [*therapy]; 5. Manipulation, Spinal; 6. Massage [*adverse effects, methods]; 7. Randomized Controlled Trials as Topic;
MESH terms:
Transcranial magnetic stimulation (TMS) for schizophrenia
1. Antipsychotic Agents [therapeutic use]; 2. Hallucinations [therapy]; 3. Headache; 4. Randomized Controlled Trials as Topic; 5. Schizophrenia [*therapy]; 6. Transcranial Magnetic Stimulation [adverse effects, *methods];
MESH terms:
Alginate dressings for venous leg ulcers
1. Alginates [adverse effects, *therapeutic use]; 2. Bandages, Hydrocolloid [*adverse effects]; 3. Compression Bandages; 4. Pain Measurement; 5. Randomized Controlled Trials as Topic; 6. Varicose Ulcer [*therapy];
MESH terms:
Transcutaneous electrical nerve stimulation (TENS) for phantom pain and stump pain following amputation in adults
1. *Amputation Stumps; 2. *Pain Management; 3. Phantom Limb [*therapy]; 4. *Transcutaneous Electric Nerve Stimulation;
MESH terms:
Effects of total fat intake on body weight
1. *Energy Intake; 2. *Portion Size; 3. *Waist Circumference; 4. *Weight Loss; 5. Age Factors; 6. Body Mass Index; 7. Body Weight; 8. Dietary Fats [*administration & dosage]; 9. Obesity [diet therapy]; 10. Randomized Controlled Trials as Topic;
MESH terms:
Selenium supplementation for critically ill adults
1. *Dietary Supplements; 2. Antioxidants [adverse effects, *therapeutic use]; 3. Azoles [adverse effects, *therapeutic use]; 4. Critical Illness [mortality, *therapy]; 5. Isoindoles; 6. Organoselenium Compounds [adverse effects, *therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Sodium Selenite [*therapeutic use];
MESH terms:
Hyperbaric oxygen therapy for acute coronary syndrome
1. Acute Coronary Syndrome [mortality, *therapy]; 2. Angina, Unstable [mortality, *therapy]; 3. Hyperbaric Oxygenation [*mortality]; 4. Myocardial Infarction [mortality, *therapy]; 5. Randomized Controlled Trials as Topic;
MESH terms:
Oral zinc for the prevention of hyperbilirubinaemia in neonates
1. Administration, Oral; 2. Hyperbilirubinemia, Neonatal [epidemiology, *prevention & control]; 3. Incidence; 4. Phototherapy; 5. Randomized Controlled Trials as Topic; 6. Zinc [*administration & dosage];
MESH terms:
Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development
1. *Breast Feeding; 2. *Child Development; 3. *Growth; 4. Attention; 5. Fatty Acids, Unsaturated [*administration & dosage]; 6. Intelligence; 7. Language Development; 8. Problem Solving; 9. Psychomotor Performance; 10. Randomized Controlled Trials as Topic; 11. Visual Acuity;
MESH terms:
Capsaicin for non‐allergic rhinitis
1. Anti‐Inflammatory Agents [*therapeutic use]; 2. Budesonide [therapeutic use]; 3. Capsaicin [administration & dosage, *therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. Rhinitis [*drug therapy];
MESH terms:
Pilates for low back pain
1. Exercise Movement Techniques [adverse effects, *methods]; 2. Low Back Pain [*therapy]; 3. Randomized Controlled Trials as Topic; 4. Time Factors;
MESH terms:
Electromagnetic therapy for treating venous leg ulcers
1. *Wound Healing; 2. Magnetic Field Therapy [*methods]; 3. Randomized Controlled Trials as Topic; 4. Varicose Ulcer [*therapy];
MESH terms:
Massage therapy for preventing pressure ulcers
1. Massage [*methods]; 2. Pressure Ulcer [*prevention & control];
MESH terms:
Transcutaneous electrical nerve stimulation for acute pain
1. Acute Pain [etiology, *therapy]; 2. Pain Measurement; 3. Randomized Controlled Trials as Topic; 4. Transcutaneous Electric Nerve Stimulation [*methods];
MESH terms:
Qigong for the primary prevention of cardiovascular disease
1. *Qigong; 2. Blood Pressure [physiology]; 3. Cardiovascular Diseases [*prevention & control]; 4. Lipids [blood]; 5. Randomized Controlled Trials as Topic;
MESH terms:
Vitamin K for upper gastrointestinal bleeding in people with acute or chronic liver diseases
1. Acute Disease; 2. Antifibrinolytic Agents [*therapeutic use]; 3. Chronic Disease; 4. Gastrointestinal Hemorrhage [*drug therapy, etiology]; 5. Liver Diseases [*complications]; 6. Vitamin K [*therapeutic use];
MESH terms:
Chinese herbal medicine for treating recurrent urinary tract infections in women
1. *Phytotherapy; 2. Acute Disease; 3. Drugs, Chinese Herbal [*therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. Recurrence; 6. Urinary Tract Infections [*drug therapy, prevention & control];
MESH terms:
Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance
1. *Dietary Supplements; 2. Diabetes Mellitus, Type 2 [*prevention & control]; 3. Insulin Resistance; 4. Randomized Controlled Trials as Topic; 5. Zinc [*administration & dosage];
MESH terms:
Oral protein calorie supplementation for children with chronic disease
1. Chronic Disease; 2. Cystic Fibrosis [*complications]; 3. Dietary Proteins [administration & dosage, adverse effects]; 4. Dietary Supplements [*adverse effects]; 5. *Energy Intake; 6. Neoplasms [*complications]; 7. Nutrition Disorders [etiology, *therapy]; 8. *Nutritional Status; 9. Outcome Assessment, Health Care; 10. Quality of Life; 11. Randomized Controlled Trials as Topic; 12. Survival Analysis;
MESH terms:
Alginate dressings for treating pressure ulcers
1. Alginates [*administration & dosage]; 2. *Bandages; 3. Bandages, Hydrocolloid; 4. Dextrans [administration & dosage]; 5. Glucuronic Acid [administration & dosage]; 6. Hexuronic Acids [administration & dosage]; 7. Hyperthermia, Induced [methods]; 8. Pressure Ulcer [*therapy]; 9. Randomized Controlled Trials as Topic; 10. Silver Compounds [administration & dosage]; 11. Silver Sulfadiazine [administration & dosage]; 12. Sulfadiazine [administration & dosage];
MESH terms:
Tong‐xin‐luo capsule for patients with coronary heart disease after percutaneous coronary intervention
1. *Percutaneous Coronary Intervention; 2. Angina Pectoris [prevention & control]; 3. Capsules; 4. Cause of Death; 5. Coronary Disease [*drug therapy]; 6. Coronary Restenosis [*prevention & control]; 7. Drugs, Chinese Herbal [*therapeutic use]; 8. Heart Failure [prevention & control]; 9. Myocardial Infarction [prevention & control]; 10. Randomized Controlled Trials as Topic; 11. Secondary Prevention [*methods]; 12. Treatment Outcome;
MESH terms:
L‐acetylcarnitine for treating fragile X syndrome
1. Acetylcarnitine [administration & dosage, *therapeutic use]; 2. Administration, Oral; 3. Attention Deficit Disorder with Hyperactivity [drug therapy]; 4. Fragile X Syndrome [*drug therapy]; 5. Randomized Controlled Trials as Topic; 6. Vitamin B Complex [*therapeutic use];
MESH terms:
Chelation for autism spectrum disorder (ASD)
1. *Chelation Therapy [adverse effects]; 2. Administration, Oral; 3. Chelating Agents [*administration & dosage, adverse effects]; 4. Child Development Disorders, Pervasive [blood, *therapy]; 5. Glutathione [administration & dosage]; 6. Metals, Heavy [blood]; 7. Randomized Controlled Trials as Topic; 8. Skin Cream [administration & dosage]; 9. Succimer [administration & dosage, adverse effects];
MESH terms:
Vitamin D for the treatment of chronic painful conditions in adults
1. Arthritis, Rheumatoid [drug therapy]; 2. Chronic Pain [*drug therapy, etiology]; 3. Ergocalciferols [adverse effects, therapeutic use]; 4. Hydroxycholecalciferols [adverse effects, therapeutic use]; 5. Musculoskeletal Pain [drug therapy]; 6. Osteoarthritis, Knee [drug therapy]; 7. Polymyalgia Rheumatica [drug therapy]; 8. Randomized Controlled Trials as Topic; 9. Vitamin D [adverse effects, *therapeutic use]; 10. Vitamin D Deficiency [complications, drug therapy]; 11. Vitamins [adverse effects, *therapeutic use];
MESH terms:
Saline nasal irrigation for acute upper respiratory tract infections
1. Acute Disease; 2. Common Cold [therapy]; 3. Laryngitis [therapy]; 4. Nasal Lavage [adverse effects, *methods]; 5. Pharyngitis [therapy]; 6. Randomized Controlled Trials as Topic; 7. Respiratory Tract Infections [*therapy]; 8. Rhinitis [therapy]; 9. Sinusitis [therapy]; 10. Sodium Chloride [adverse effects, *therapeutic use];
MESH terms:
Feverfew for preventing migraine
1. Migraine Disorders [*prevention & control]; 2. *Phytotherapy; 3. Plant Extracts [therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. *Tanacetum parthenium;
MESH terms:
Chinese medicinal herbs for mumps
1. Drugs, Chinese Herbal [adverse effects, *therapeutic use]; 2. Mumps [*drug therapy]; 3. Phytotherapy [adverse effects, *methods];
MESH terms:
Exercise programs for people with dementia
1. Activities of Daily Living; 2. Caregivers; 3. Cognition; 4. Dementia [psychology, *rehabilitation]; 5. Depression [rehabilitation]; 6. Exercise; 7. Exercise Therapy [*methods]; 8. Motor Activity; 9. Randomized Controlled Trials as Topic;
MESH terms:
Omega 3 fatty acids for preventing or slowing the progression of age‐related macular degeneration
1. Disease Progression; 2. Fatty Acids, Omega‐3 [adverse effects, *therapeutic use]; 3. Macular Degeneration [*prevention & control]; 4. Randomized Controlled Trials as Topic;
MESH terms:
Quinine for muscle cramps
1. Drug Therapy, Combination; 2. Lidocaine [therapeutic use]; 3. Muscle Cramp [*drug therapy]; 4. Muscle Relaxants, Central [adverse effects, *therapeutic use]; 5. Quinine [adverse effects, *therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Theophylline [therapeutic use]; 8. Vitamin E [therapeutic use]; 9. Vitamins [therapeutic use];
MESH terms:
Reiki for depression and anxiety
1. Anxiety [*therapy]; 2. Depression [*therapy]; 3. Prostatic Neoplasms [psychology]; 4. Randomized Controlled Trials as Topic; 5. Therapeutic Touch [*methods];
MESH terms:
Xylitol‐containing products for preventing dental caries in children and adults
1. Candy; 2. Cariostatic Agents [*administration & dosage]; 3. Dental Caries [*prevention & control]; 4. Dentition, Permanent; 5. Fluorides; 6. Oral Health; 7. Oral Hygiene [*methods]; 8. Randomized Controlled Trials as Topic; 9. Tablets; 10. Toothpastes [chemistry]; 11. Xylitol [*administration & dosage];
MESH terms:
Honey as a topical treatment for wounds
1. *Honey; 2. *Wound Healing; 3. Administration, Topical; 4. Apitherapy [*methods]; 5. Burns [*therapy]; 6. Leg Ulcer [therapy]; 7. Pressure Ulcer [therapy]; 8. Randomized Controlled Trials as Topic; 9. Surgical Wound Infection [therapy]; 10. Varicose Ulcer [therapy]; 11. Wounds and Injuries [*therapy];
MESH terms:
Muscle energy technique for non‐specific low‐back pain
1. Acute Pain [*therapy]; 2. Chronic Pain [*therapy]; 3. Low Back Pain [therapy]; 4. Manipulation, Osteopathic; 5. Muscle Contraction [*physiology]; 6. Randomized Controlled Trials as Topic; 7. Selection Bias;
MESH terms:
Morita therapy for anxiety disorders in adults
1. Acceptance and Commitment Therapy [methods]; 2. Activities of Daily Living; 3. Anti‐Anxiety Agents [therapeutic use]; 4. Anxiety Disorders [*psychology, *therapy]; 5. Bed Rest; 6. Psychotherapy [*methods]; 7. Randomized Controlled Trials as Topic; 8. Work;
MESH terms:
Dance movement therapy for depression
1. *Movement; 2. Antidepressive Agents [therapeutic use]; 3. Dance Therapy [*methods]; 4. Depression [*therapy]; 5. Empathy; 6. Psychotherapy; 7. Randomized Controlled Trials as Topic; 8. Sensation;
MESH terms:
Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
1. Blood Glucose [metabolism]; 2. Body Mass Index; 3. Cardiovascular Diseases [*prevention & control]; 4. Cholesterol [blood]; 5. Diabetes Mellitus, Type 2 [blood, *therapy]; 6. Drugs, Chinese Herbal [therapeutic use]; 7. Glycated Hemoglobin [analogs & derivatives, metabolism]; 8. Randomized Controlled Trials as Topic; 9. *Reishi; 10. Risk Factors;
MESH terms:
Chinese herbal medicines for hypothyroidism
1. Drugs, Chinese Herbal [*therapeutic use]; 2. Hypothyroidism [*drug therapy]; 3. Phytotherapy [*methods]; 4. Yang Deficiency [*drug therapy];
MESH terms:
Acupuncture for mumps in children
1. Acupuncture Therapy [*methods]; 2. Drugs, Chinese Herbal [therapeutic use]; 3. Fever [therapy]; 4. Mumps [*therapy];
MESH terms:
Homeopathic Oscillococcinum® for preventing and treating influenza and influenza‐like illness
1. Ducks; 2. Homeopathy [*methods]; 3. Influenza Vaccines [therapeutic use]; 4. Influenza, Human [prevention & control, *therapy]; 5. Liver Extracts [therapeutic use]; 6. Myocardium; 7. Randomized Controlled Trials as Topic; 8. Syndrome; 9. Tissue Extracts [*therapeutic use];
MESH terms:
Complementary therapies for acne vulgaris
1. *Complementary Therapies [adverse effects]; 2. Acne Vulgaris [pathology, *therapy]; 3. Acupuncture Points; 4. Acupuncture Therapy [methods]; 5. Bee Venoms [therapeutic use]; 6. Plant Preparations [therapeutic use]; 7. Quality of Life; 8. Selection Bias; 9. Tea Tree Oil [therapeutic use]; 10. Treatment Outcome;
MESH terms:
Vitamin B and its derivatives for diabetic kidney disease
1. Albuminuria [drug therapy]; 2. Diabetic Nephropathies [*drug therapy]; 3. Folic Acid [therapeutic use]; 4. Pyridoxamine [therapeutic use]; 5. Randomized Controlled Trials as Topic; 6. Selection Bias; 7. Thiamine [analogs & derivatives, therapeutic use]; 8. Vitamin B 12 [therapeutic use]; 9. Vitamin B 6 [therapeutic use]; 10. Vitamin B Complex [adverse effects, *therapeutic use]; 11. Vitamins [adverse effects, *therapeutic use];
MESH terms:
Mailuoning for acute ischaemic stroke
1. *Phytotherapy [adverse effects]; 2. Brain Ischemia [*drug therapy]; 3. Drugs, Chinese Herbal [adverse effects, *therapeutic use]; 4. Fibrinolytic Agents [adverse effects, *therapeutic use]; 5. Randomized Controlled Trials as Topic; 6. Recovery of Function; 7. Stroke [*drug therapy];